Hepatitis C virus in hemophilia: Health-related quality of life after successful treatment in the sixth Hemophilia in the Netherlands study

Cas J Isfordink, Samantha C Gouw*, Erna C van Balen, Shermarke Hassan, Erik A M Beckers, Johanna G van der Bom, Michiel Coppens, Jeroen Eikenboom, Kathelijn Fischer, Louise Hooimeijer, Frank W G Leebeek, Frits R Rosendaal, Saskia E M Schols, Cees Smit, Lize F D van Vulpen, Eveline P Mauser-Bunschoten

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Article number12616
Pages (from-to)e12616
Number of pages11
JournalResearch and practice in thrombosis and haemostasis
Volume5
Issue number8
DOIs
Publication statusPublished - Dec 2021

Keywords

  • direct-acting antivirals
  • hepatitis C virus
  • hemophilia A
  • hemophilia B
  • patient reported outcome measures
  • RAND-36
  • viral hepatitis
  • PATIENT-REPORTED OUTCOMES
  • BLEEDING DISORDERS
  • INFECTION
  • GENOTYPE
  • DISEASE
  • IMPACT
  • LIVER
  • RISK

Cite this